AN2 Therapeutics Target Price

Where could ANTX trade next? Consensus target price: $9.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.73

Average Target Price

$9.00

57.1% upside

2 analysts in the last 4 months

High: $9 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-20	Guggenheim	$9	57.1% upside
2026-05-14	Leerink PartnersJoseph Schwartz	$9	57.1% upside
2025-05-05	JMP SecuritiesRoy Buchanan	$2	65.1% downside
2024-07-03	Leerink PartnersJoseph Schwartz	$5	12.7% downside
2024-05-16	Evercore ISILiisa Bayko	$2	65.1% downside
2024-04-02	JMP SecuritiesRoy Buchanan	$6	4.7% upside
2022-11-14	Leerink Partners	$25	336.3% upside
2022-04-19	Evercore ISI	$25	336.3% upside
2022-04-19	Oppenheimer	$22	283.9% upside

AN2 Therapeutics (ANTX) FAQ

The latest target price for ANTX is $9. Investors often review this figure alongside AN2 Therapeutics's historical trend and sector peers before judging valuation or financial health.

AN2 Therapeutics trades near $5.73 while the consensus target sits at $9 (57.1% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ANTX's target price ($9), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.